Search results
Can-Fite receives FDA IND clearance for Phase IIb MASH treatment trial
Clinical Trials Arena via Yahoo Finance· 6 days agoIIa study, we are proud to develop a new potential treatment to address this disease.” In August...
Breed s Hill Capital LLC Makes New $482,000 Investment in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoBreed s Hill Capital LLC acquired a new stake in Johnson & Johnson (NYSE:JNJ – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange ...
Kessler Investment Group LLC Reduces Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoKessler Investment Group LLC reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 98.8% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission ...
E Fund Management Co. Ltd. Increases Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 4 days agoE Fund Management Co. Ltd. grew its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 10.5% during the 4th quarter, according to the company in its most recent disclosure with ...
Takeda tackles $900m restructuring plan after generics hurt annual profits
Pharmaceutical Technology via Yahoo Finance· 7 days agoTakeda shared progress in an earnings call from six late-stage programmes that it says have the...
I’m 66 and Have Dry Skin Around My Eyes. Will Concealer Help?
The Cut· 6 days agoQ: I hate to pile on to the never-ending search for under-eye fixes, but I have a question about...
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters· 7 days ago, opens new tab blockbuster arthritis drug Humira in the coming weeks after it posted mixed results in the first three months of 2024. In the wake of February's U.S. Food and Drug Administration ...
Nektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 5 days agoNektar Therapeutics (NASDAQ:NKTR) Q1 2024 Earnings Call Transcript May 9, 2024 Nektar Therapeutics...
27 Products From Amazon’s 'Internet Famous' Section That Are Actually Worth The Hype
The Huffington Post· 5 days agoTikTok may have made these cult-fave skincare products and cute pieces famous, but the rave reviews...
Johnson & Johnson (NYSE:JNJ) Shares Sold by Baxter Bros Inc.
ETF DAILY NEWS· 7 days agoBaxter Bros Inc. reduced its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 3.9% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission ...